The company is looking to achieve an ambitious goal in the development and testing of drugs and explore the possibility of "printing" organs. If the first part works (3d bioprinted liver tissue) and is economically feasible - it will be gamechanger in cutting down the costs for pharma companies to bring drugs to market.
This may be the future - and ONVO is the public company where one may acquire direct ownership in this space(tissue regeneration) that I'm aware of. Are there others? Would like some guidance on that.
On to the technicals - the shares have consistently been under selling pressure since the beginning of the year. They are reaching important relative lows if one looks at the weekly and monthly charts. Given that they have sold off for some time now and are near higher timeframe support - this may the stock in a favorable position for accumulation.
I am currently looking at the $3 - 3.4 price level as one entry point and acquiring more shares if price retraces to the $2.75 level. I will be looking to acquire long term call options ( as of now Jan 2017) and possibly selling puts.
I'm usually not of a fan sub-$5 issues, but there is sufficient liquidity (+1m avg daily volume) and the upside potential good for the risk taken. My initial sell point would be the the $5.50 level.
This may be the future - and ONVO is the public company where one may acquire direct ownership in this space(tissue regeneration) that I'm aware of. Are there others? Would like some guidance on that.
On to the technicals - the shares have consistently been under selling pressure since the beginning of the year. They are reaching important relative lows if one looks at the weekly and monthly charts. Given that they have sold off for some time now and are near higher timeframe support - this may the stock in a favorable position for accumulation.
I am currently looking at the $3 - 3.4 price level as one entry point and acquiring more shares if price retraces to the $2.75 level. I will be looking to acquire long term call options ( as of now Jan 2017) and possibly selling puts.
I'm usually not of a fan sub-$5 issues, but there is sufficient liquidity (+1m avg daily volume) and the upside potential good for the risk taken. My initial sell point would be the the $5.50 level.